Open AccessOutcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support
Author(s) -
Vandan Upadhyaya,
Abbas Alshami,
Ishan Patel,
Steven Douedi,
A. G. Quinlan,
Tresy Thomas,
Joni Prentice,
Dawn Calderon,
Arif Asif,
Shuvendu Sen,
Aditya Mehra,
Mohammad A. Hossain
Publication year - 2021
Publication title -
journal of clinical medicine research
Language(s) - English
Resource type - Journals
eISSN - 1918-3011
pISSN - 1918-3003
DOI - 10.14740/jocmr4449
Subject(s) - cardiogenic shock , impella , medicine , cardiology , cardiac catheterization , renal function , percutaneous coronary intervention , ventricular assist device , intra aortic balloon pump , shock (circulatory) , myocardial infarction , heart failure , intra aortic balloon pumping
The objective of the study was to compare the renal outcomes in patients presenting with all-cause cardiogenic shock who were supported by either Impella devices (Abiomed, Danvers, MA), intra-aortic balloon pump (IABP), or vasopressors alone. Outcomes of cardiogenic shock remain poor even with the advancement of early revascularization and circulatory supportive care. Percutaneous mechanical circulatory support (MCS) device has emerged as an effective strategy in protecting end organ function especially renal function during high risk percutaneous coronary intervention (PCI) and in patients with cardiogenic shock. Currently, comparative data amongst various MCS modalities and their association with improvement of renal function in cardiogenic shock patients have not been well characterized.